BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lahrouchi N, Lodder EM, Mansouri M, Tadros R, Zniber L, Adadi N, Clur SB, van Spaendonck-Zwarts KY, Postma AV, Sefiani A, Ratbi I, Bezzina CR. Exome sequencing identifies primary carnitine deficiency in a family with cardiomyopathy and sudden death. Eur J Hum Genet 2017;25:783-7. [PMID: 28295041 DOI: 10.1038/ejhg.2017.22] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Gray B, Tester DJ, Wong LC, Chanana P, Jaye A, Evans JM, Baruteau A, Evans M, Fleming P, Jeffrey I, Cohen M, Tfelt-hansen J, Simpson MA, Ackerman MJ, Behr ER. Noncardiac genetic predisposition in sudden infant death syndrome. Genet Med 2019;21:641-9. [DOI: 10.1038/s41436-018-0131-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lin Y, Zhang W, Huang C, Lin C, Lin W, Peng W, Fu Q, Chen D. Increased detection of primary carnitine deficiency through second-tier newborn genetic screening. Orphanet J Rare Dis 2021;16:149. [PMID: 33757571 DOI: 10.1186/s13023-021-01785-6] [Reference Citation Analysis]
3 Yang X, Li Q, Wang F, Yan L, Zhuang D, Qiu H, Li H, Chen L. Newborn Screening and Genetic Analysis Identify Six Novel Genetic Variants for Primary Carnitine Deficiency in Ningbo Area, China. Front Genet 2021;12:686137. [PMID: 34249102 DOI: 10.3389/fgene.2021.686137] [Reference Citation Analysis]
4 Hausner EA, Elmore SA, Yang X. Overview of the Components of Cardiac Metabolism. Drug Metab Dispos 2019;47:673-88. [PMID: 30967471 DOI: 10.1124/dmd.119.086611] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
5 Wang W, Bai M, Jiang T, Li C, Li P, Zhou H, Wang Z, Li L, Jiang H. Clozapine-induced reduction of l-carnitine reabsorption via inhibition/down-regulation of renal carnitine/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice. Toxicology and Applied Pharmacology 2019;363:47-56. [DOI: 10.1016/j.taap.2018.11.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
6 Cesar S. Neuromuscular diseases with hypertrophic cardiomyopathy. Glob Cardiol Sci Pract 2018;2018:27. [PMID: 30393639 DOI: 10.21542/gcsp.2018.27] [Reference Citation Analysis]
7 Manta A, Spendiff S, Lochmüller H, Thompson R. Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'. J Neuromuscul Dis 2021;8:401-17. [PMID: 33720849 DOI: 10.3233/JND-200621] [Reference Citation Analysis]
8 Wilson C, Knoll D, de Hora M, Kyle C, Glamuzina E, Webster D. The decision to discontinue screening for carnitine uptake disorder in New Zealand. J Inherit Metab Dis 2019;42:86-92. [PMID: 30740730 DOI: 10.1002/jimd.12030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
9 Bene J, Szabo A, Komlósi K, Melegh B. Mass Spectrometric Analysis of L-carnitine and its Esters: Potential Biomarkers of Disturbances in Carnitine Homeostasis. Curr Mol Med 2020;20:336-54. [PMID: 31729298 DOI: 10.2174/1566524019666191113120828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Yang XF, Liu GS, Yi B. Primary carnitine deficiency in two sisters with intractable epilepsy and reversible metabolic cardiomyopathy: Two case reports. Exp Ther Med 2020;20:118. [PMID: 33005244 DOI: 10.3892/etm.2020.9246] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Perrone S, Lembo C, Moretti S, Prezioso G, Buonocore G, Toscani G, Marinelli F, Nonnis-Marzano F, Esposito S. Sudden Infant Death Syndrome: Beyond Risk Factors. Life (Basel) 2021;11:184. [PMID: 33652660 DOI: 10.3390/life11030184] [Reference Citation Analysis]
12 Vasiljevski ER, Summers MA, Little DG, Schindeler A. Lipid storage myopathies: Current treatments and future directions. Prog Lipid Res. 2018;72:1-17. [PMID: 30099045 DOI: 10.1016/j.plipres.2018.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]